Company profile for Liquidia Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hyper...
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
419 Davis Drive, Suite 100 Morrisville, NC 27560
Telephone
Telephone
+1 919-328-4400
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://liquidia.com/news-releases/news-release-details/liquidia-corporation-present-upcoming-healthcare-investment

PRESS RELEASE
03 Nov 2025

https://liquidia.com/news-releases/news-release-details/liquidia-corporation-reports-third-quarter-2025-financial

PRESS RELEASE
03 Nov 2025

https://liquidia.com/news-releases/news-release-details/liquidia-corporation-report-third-quarter-2025-financial-results

PRESS RELEASE
27 Oct 2025

https://liquidia.com/news-releases/news-release-details/liquidia-corporation-host-rd-day-new-york-city-october-28-2025

PRESS RELEASE
07 Oct 2025

https://liquidia.com/news-releases/news-release-details/liquidia-present-clinical-data-ascent-trial-chest-2025-annual

PRESS RELEASE
29 Sep 2025

https://liquidia.com/news-releases/news-release-details/liquidia-announces-poster-presentations-pulmonary-hypertension

PRESS RELEASE
11 Sep 2025

ABOUT THIS PAGE

Contact Liquidia Corporation and get a quotation

Liquidia Corporation is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of MOLD TEMPLATE FORMULATION 1 FOR PRINT® PROCESS bulk with DMF offered by Liquidia Corporation

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty